Skip to content Skip to navigation

Drug Delivery

Pulmatrix, Inc.
Pulmatrix, Inc.
99 Hayden Avenue Suite 390 Lexington, MA 02421 USA

Pulmatrix is developing new breakthrough therapies with the vision of fundamentally changing the way we treat, prevent and control infectious and progressive respiratory diseases.

pSivida Corporation
pSivida Corporation
400 Pleasant Street Watertown, MA 02472 USA

pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.

Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals
101 Rogers Street Cambridge, MA 02142 USA

Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery and development of therapeutic radiopharmaceuticals and targeted molecular imaging agents for use in oncology and cardiology.

Micro Chips Inc.
Micro Chips Inc.
6B Preston Court Bedford, MA 01730 USA

MicroCHIPS is pioneering intelligent implanted devices designed to improve the health of millions of people with chronic conditions that require careful monitoring and precise therapy.

FEI Company
FEI Company
1 Corporation Way Peabody, MA 01960 USA

FEI is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. FEI's imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Angstrom (one-tenth of a nanometer) level.

ExQor Technologies, Inc.
ExQor Technologies, Inc.
4 Longfellow Place Suite 2105 Boston, MA 02114 USA

ExQor's patented bio-nanotransport platform enables delivery of many different types of drugs throughout the body, including the brain. Uniquely and unlike almost all other nano-particles, ExQor's could also become a powerful new therapeutic in its own right.

ExQor's multiple patents cover Clathrin, a vitally essential protein responsible for transporting a very broad variety of substances—from cholesterol to neurotransmitters—to the interior of cells. Clathrin is also implicated in viral diseases, like HIV.

Elan Drug Technologies
Elan Drug Technologies
1300 Gould Drive Gainsville, GA 30504 USA

Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN). The company focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Their NanoCrystal® technology is a proven innovation for poorly water-soluble compounds, manufactured to the nanoscale it has five licensed products commercialized to date.

Aphios Corp.
Aphios Corp.
3-E Gill Street New Boston Park Woburn, MA 01801 USA

Aphios is developing enabling technology platforms and enhanced therapeutics for health maintenance, disease prevention and the treatment of certain infectious diseases, cancers and CNS disorders.

Ad-Vance Magnetics, Inc.
Ad-Vance Magnetics, Inc.
625 Monroe Street Rochester, IN 46975 USA

Ad-Vance Engineers have solved a variety of magnetic shielding problems. In addition, substantial cuts in shielding costs are possible by using our existing tooling. From simple components to complete systems.

Ad-Vance Magnetics offers: Design and Consultation, AD-MU Shielding Alloys, In-House Tool Room for Manufacturing Magnetic Shields, Custom Fabricated CRT Shields, Heat Treating for Optimum Magnetic Shielding Characteristics, State Of The Art Equipment, Processing and Manufacturing, Machining Centers, Precision Laser Cutting

Acusphere, Inc.
Acusphere, Inc.
890 East Street Tewksbury, MA 01876 USa

Acusphere is a specialty pharmaceutical company that develops new drugs using our core proprietary microsphere technology. Our technology may be applied to drug targets in a wide variety of clinical applications and disease areas offering potentially significant benefits such as improved safety, efficacy, patient compliance, ease of use, expanded indications or reduced cost. Our current product candidates are designed to advance medical management within cardiology, oncology and pulmonary disease through use of flexible and targeted delivery systems.

Pages